razoxane has been researched along with Lymphoma, B-Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trnĕný, M | 1 |
| Benesová, V; Boudová, L; Cahová, S; Dvoráková, D; Fisar, J; Holub, M; Lemez, P; Maresová, J; Slavícek, L; Stejskal, J; Svítil, P; Vásová, I | 1 |
| Ben-Yehuda, D; Lossos, IS | 1 |
1 trial(s) available for razoxane and Lymphoma, B-Cell
| Article | Year |
|---|---|
[Dexrazoxane in patients with B-lymphomas or acute leukemias in the 2nd complete remission enables further therapy with cardiotoxic anthracyclines over recommended cumulative doses].
Topics: Acute Disease; Adult; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiotonic Agents; Female; Heart; Humans; Leukemia, Myeloid; Lymphoma, B-Cell; Male; Middle Aged; Razoxane; Recurrence; Remission Induction | 2004 |
2 other study(ies) available for razoxane and Lymphoma, B-Cell
| Article | Year |
|---|---|
[Dexrazoxane and cardiotoxicity in repeatedly treated patients].
Topics: Acute Disease; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiotonic Agents; Heart; Humans; Leukemia, Myeloid; Lymphoma, B-Cell; Razoxane; Recurrence | 2004 |
Cutaneous and subcutaneous necrosis following dexrazoxane-CHOP therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Agents; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Necrosis; Prednisone; Razoxane; Skin; Vincristine | 1999 |